Publications

May 2020 (Revised March 2022)
Case

The Coronavirus (COVID-19) Pandemic and the Global Economy (A)

By: Alberto Cavallo and Christian Godwin

In April 2020, the world struggled to contain the exponential escalation of the coronavirus (COVID-19) pandemic. Dozens of countries had imposed restrictions on travel, work, and social gatherings. A large share of the global population was under lockdowns and... View Details

May 2020
Teaching Note

Baskits Inc.

By: Richard S. Ruback, Royce Yudkoff and Ahron Rosenfeld

Teaching Note for HBS Case No. 217-001. Robin Kovitz (MBA 2007) acquired Baskits, a Canadian gift basket company, in October of 2014. The business was highly seasonal with two-thirds of its sales occurring in November and December. Baskits dealt with its seasonality... View Details

Keywords: Operations; Performance Improvement; Canada

May 2020
Case

Big Boom Beverages: Fight or Flight?

By: Stephen A. Greyser and William Ellet

Four college friends market a beverage that combines ingredients like those in a drink they consumed in college bars. It includes a caffeinated energy drink, malt liquor, and a soft drink flavoring. They launch the business, Big Boom Beverages (BBB), with their own... View Details

Keywords: Alcoholic Beverages; Energy Drinks; Regulation; Entrepreneurship; Ethics; Marketing Communications; Corporate Social Responsibility and Impact; Reputation; Communication Strategy; Decision Making

May 2020
Teaching Note

Big Boom Beverages: Fight or Flight? (Brief Case)

By: Stephen A. Greyser and William Ellet

Teaching Note for HBS Brief Case No. 920-557. The case addresses analysis and decisions related to the entrepreneurial life of a distinctive energy beverage, including its niche market launch, early problems, reformulation, social media impact, market success, and... View Details

Keywords: Alcoholic Beverages; Energy Drinks; Regulation; Entrepreneurship; Ethics; Marketing Communications; Corporate Social Responsibility and Impact; Reputation; Communication Strategy; Decision Making

May 2020 (Revised July 2020)
Teaching Note

Brand Activism: Nike and Colin Kaepernick

By: Jill Avery and Koen Pauwels

Teaching Note for HBS Case No. 519-046. Nike’s selection of politically polarizing Colin Kaepernick as the spokesperson for the thirtieth anniversary of its iconic “Just Do It” campaign catapulted the brand into the media spotlight and made it a political flashpoint... View Details

Keywords: Marketing; Brands and Branding; Advertising; Advertising Campaigns; Marketing Strategy; Marketing Communications; Corporate Social Responsibility and Impact; Consumer Products Industry; Sports Industry; United States; North America

May 2020
Article

How History's Great Leaders Managed Anxiety: Historian Nancy Koehn on What Lincoln, Shackleton, and Others Knew About Handling Collective Anxiety—and Their Own—During a Crisis

By: Nancy F. Koehn

Keywords: Leadership; Crisis Management

Article

How to End the Plasma Shortage for Coronavirus Patients

By: Scott Duke Kominers

Those who have recovered from the virus will donate more blood if given the right incentives. View Details

Keywords: COVID-19; Convalescent Plasma; Health Pandemics; Health Care and Treatment; Market Design; Strategy

May 2020
Teaching Note

Kraft Heinz: The $8 Billion Brand Write-Down

By: Jill Avery

Teaching Note for HBS Case No. 519-076. On Friday, February 22, 2019, following an unexpected and disappointing earnings report, The Kraft Heinz Company’s stock price fell 27%, wiping out $16 billion in market value. CEO Bernardo Hees had announced that the company had... View Details

Keywords: Marketing; Marketing Strategy; Brands and Branding; Consumer Products Industry; Food and Beverage Industry; United States

May 2020
Teaching Note

The Video-Streaming Wars in 2019: Can Disney Catch Netflix?

By: Anita Elberse

May 8, 2020
Article

Lead Your Team Into a Post-Pandemic World

By: Hubert Joly

The unprecedented COVID-19 pandemic has tested leaders, especially as it relates to how they lead their workers. As the crisis goes on, many that the author has spoken with have begun to frame it around three distinct phases: The Shelter-in-Place Phase, the Re-opening... View Details

Keywords: COVID-19; Re-opening; Health Pandemics; Leadership; Employees; Communication; Human Needs

Find at Harvard

May 8, 2020
Article

Which Covid-19 Data Can You Trust?

By: Satchit Balsari, Caroline Buckee and Tarun Khanna

The COVID-19 pandemic has produced a tidal wave of data, but how much of it is any good? And as a layperson, how can you sort the good from the bad? The authors suggest a few strategies for dividing the useful data from the misleading: Beware of data that’s too broad... View Details

Keywords: COVID-19 Pandemic; Health Pandemics; Analytics and Data Science

2020
Working Paper

Anchors Aweigh: Analysis of Anchor Limited Partner Investors in Impact Investment Funds

By: Shawn A. Cole, T. Robert Zochowski, Fanele Mashwama and Heather McPherson

This note describes results from a survey of “anchor investors” in impact funds. Anchor investors are described as “generally the first investor to make a substantial capital commitment to a fund,” (according to the Global Impact Investing Network, “GIIN”) and their... View Details

Keywords: Impact Investment Funds; Anchor Investors; Investment; Surveys; Analysis

May 2020 (Revised July 2020)
Case

iPod: The Perfect Thing?

By: Robert J. Dolan

May 27, 2020
Article

Leapfrog Leaders: How Lowlighting Content, and Highlighting Cognitive Structure and Dynamics Can Leapfrog Leaders to the Next Level

By: Derek Cabrera, Laura Cabrera and Hise O. Gibson

2020
Working Paper

Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design

By: Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver

COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order... View Details

Keywords: COVID-19; Convalescent Plasma; Vouchers; Health Pandemics; Health Care and Treatment; Resource Allocation; Market Design

Read Now

May 2020 (Revised October 2020)
Teaching Note

The Marriott-Starwood Merger: Navigating Brand Portfolio Strategy and Brand Architecture

By: Jill Avery and Chekitan S. Dev

In September 2016, Marriott completed its $13.3 billion acquisition of Starwood Hotels & Resorts, which added 11 brands to its already robust 19 hotel brand portfolio. Tina Edmundson, Marriott’s global brand officer, was charged with making sense of the brand portfolio... View Details

Keywords: Branding; Brand Portfolio Strategy; Brand Architecture; Hospitality Industry; Mergers ＆ Acquisitions; Marketing; Brands and Branding; Marketing Strategy; Mergers and Acquisitions; Travel Industry; Accommodations Industry; United States

May 2020
Case

WH Group and Smithfield Foods: Global Leadership During a Difficult Environment of Trade, Disease, and Sustainability

By: Ray Goldberg and Rachel Lee

2023
Working Paper

How Resilient Is Venture-Backed Innovation? Evidence from Four Decades of U.S. Patenting

By: Sabrina T. Howell, Josh Lerner, Ramana Nanda and Richard Townsend

Despite theoretical predictions to the contrary, corporate innovation is strongly pro-cyclical. In this paper, we compare innovation in the economy as a whole to that of firms backed by venture capital (VC), a source of capital associated with the most impactful young... View Details

Keywords: Recessions; Venture Capital; Innovation and Invention; Patents; Business Cycles; Economic Slowdown and Stagnation

SSRN

Read Now

May 6, 2020
Article

We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic

By: Gary P. Pisano

The ultimate solutions to the COVID-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already... View Details

Keywords: COVID-19; Health Pandemics; Strategy; Leadership